Trevi Therapeutics, Inc.TRVINASDAQ
Loading
Year-over-year net income growth rate
3Y CAGR
-4.0%/yr
Quarterly compound
Percentile
P97
Near historical high
vs 3Y Ago
0.9x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 29.54% |
| Q3 2025 | 4.06% |
| Q2 2025 | -18.97% |
| Q1 2025 | 9.42% |
| Q4 2024 | 13.80% |
| Q3 2024 | -7.21% |
| Q2 2024 | -13.30% |
| Q1 2024 | -39.39% |
| Q4 2023 | -1.60% |
| Q3 2023 | -7.74% |
| Q2 2023 | -11.62% |
| Q1 2023 | -16.28% |
| Q4 2022 | 33.40% |
| Q3 2022 | -2.66% |
| Q2 2022 | -9.86% |
| Q1 2022 | 13.98% |
| Q4 2021 | -17.44% |
| Q3 2021 | 25.92% |
| Q2 2021 | -17.00% |
| Q1 2021 | 12.10% |
| Q4 2020 | -29.07% |
| Q3 2020 | 0.08% |
| Q2 2020 | 12.85% |
| Q1 2020 | -29.62% |
| Q4 2019 | 11.24% |
| Q3 2019 | -0.26% |
| Q2 2019 | -52.98% |
| Q1 2019 | 19.73% |
| Q4 2018 | -5.80% |
| Q3 2018 | -16.39% |
| Q2 2018 | -19.92% |
| Q1 2018 | -16.24% |
| Q4 2017 | 0.00% |